Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on L 1. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Discover a cost-effective, metal-free synthesis method for 3,4,5-trisubstituted 1,2,4-triazoles. Eliminate anhydrous conditions and heavy metal catalysts to reduce production costs and supply chain risks.
Solve supply chain risks in chiral synthesis with this novel protonic acid catalyst. Achieve 98% ee and 96% yield in ruthenium-catalyzed reactions. Contact us for custom synthesis.
Discover copper-catalyzed indole synthesis with 74-90% yields, nitrogen protection, and 110°C mild conditions. Reduce R&D costs and supply chain risks for pharmaceutical intermediates.
Discover a novel palladium-catalyzed method for quinoline-4(1H)-ketone synthesis with high yield, broad substrate tolerance, and simplified post-treatment. Reduce production costs and supply chain risks for pharmaceutical intermediates.
Solve supply chain risks with metal-free 5-trifluoromethyl triazole synthesis. 80%+ yields, no azides, scalable to 100MT. Contact for custom synthesis.
Reduce supply chain risks with metal-free deracemization process. 90%+ yield, 95% ee, and scalable production for chiral alcohol intermediates.
Overcome synthesis challenges of trisubstituted allenes with mild reaction conditions, high functional group tolerance, and 70%+ yields. Reduce supply chain risks for API manufacturing.
Discover a one-step Pd-catalyzed method for 1,5-dihydro-2H-pyrrole-2-ketone with 70-92% yield. Reduce production costs and supply chain risks for pharmaceutical intermediates.
Solve heavy metal contamination in benzothiazole synthesis. Our CDMO expertise scales this visible light method with >99% purity and 98% yield for your API production.
Discover how iodine-catalyzed metal-free synthesis of 3-arylthioimidazo[1,5-a]N-heterocycles solves transition metal contamination risks and improves yield for pharmaceutical intermediates.
Discover a cost-efficient, scalable synthesis method for furo[3,2-b]pyridine derivatives, eliminating precious metal use and reducing production costs for JAK1 inhibitor development.
Discover a green, high-yield route for S,S-2,8-diazabicyclononane that eliminates expensive reagents and reduces waste, ensuring supply chain stability for moxifloxacin manufacturing.
Solve supply chain risks and low yields in anticancer intermediate production. Discover a 4-step, 84% yield route using common raw materials. Contact us for scalable CDMO solutions.
Discover a novel tadalafil synthesis method with 91.5% yield, eliminating hazardous piperonal and reducing equipment costs. Ideal for pharma R&D and procurement teams seeking scalable, eco-friendly production.
Discover how copper-catalyzed trifluoromethylation enables efficient quinazolinone synthesis for AChE/BuChE inhibition. Reduce production costs and scale complex molecules with CDMO expertise.
Discover how nickel-catalyzed carbonylation of ketone nitriles enables cost-efficient, high-yield production with broad functional group tolerance for pharmaceutical supply chains.
97% ee, >95% yield, low-cost industrial production of chiral alpha-hydroxy-beta-keto esters for agrochemicals. Solve supply chain risks with scalable zirconium catalysis.
Discover a novel indolocyclopentane synthesis method with >95% yield and 93% ee. Ideal for pharmaceutical R&D targeting PC-3 prostate cancer cells. Scale up with CDMO expertise.
Discover how visible light catalysis enables 90% yield 3-alkylquinoxaline-2(1H)-ketone synthesis at room temperature, reducing production costs and safety risks for pharmaceutical intermediates.
Discover how electrochemical catalysis eliminates metal catalysts and harsh conditions in benzyl alcohol production, reducing costs and supply chain risks for pharmaceutical intermediates. Contact us for scalable solutions.